Related Experiment Video

Updated: Apr 26, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

33.8K

Best practice for fever management with intravenous acetaminophen in pediatric oncology

Dorothy Dokko1

  • 1University of Pennsylvania, Philadelphia, USA odokko@gmail.com.

Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|July 20, 2014
PubMed

Insights

Intravenous acetaminophen is a safe and effective analgesic and antipyretic for children. This review evaluates its use in pediatric oncology patients, offering clinical guidance and future research recommendations.

Area of Science:

  • Pediatric Oncology
  • Pharmacology
  • Pain Management

Background:

  • Intravenous (IV) acetaminophen was approved in the US in 2011.
  • Existing literature supports the safety and efficacy of IV acetaminophen in pediatric and adult populations.
  • No studies have specifically evaluated IV acetaminophen use in pediatric oncology.

Purpose of the Study:

  • To review and apply current data on IV acetaminophen.
  • To evaluate the safety and efficacy of IV acetaminophen in pediatric cancer patients.
  • To provide clinical indications, safety profiles, and nursing implications for IV acetaminophen in this population.

Main Methods:

  • Literature review of existing studies on IV acetaminophen.
  • Application of current data to the pediatric oncology population.
  • Analysis of clinical indications, safety, efficacy, and nursing implications.

Main Results:

  • Existing literature suggests IV acetaminophen is safe and effective for children and adults.
  • The review aims to determine if pediatric cancer patients can benefit from its use.
  • Clinical indications, safety, and efficacy profiles will be presented.

Conclusions:

  • Further research is needed to confirm the benefits of IV acetaminophen in pediatric oncology.
  • Recommendations for future study will be provided.
  • The article will guide the use of IV acetaminophen in children with cancer.

Keywords:
feverintravenous acetaminophenpediatric oncology

More Related Videos

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

27.2K
Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

17.5K

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.6K
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
271